Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

An enlarging pacemaker pocket: A case report of a plasmablastic lymphoma arising as a primary tumor around a cardiac pacemaker and systematic literature review of various malignancies arising at the pacemaker pocket.

Zarifi C, Deutsch S, Dullet N, Mukherjee KK, Mukherjee A, Abubaker F.

J Cardiol Cases. 2017 Oct 13;17(2):41-43. doi: 10.1016/j.jccase.2017.09.006. eCollection 2018 Feb.

2.

Plasmablastic Lymphoma with Coexistence of Chronic Lymphocytic Leukemia in an Immunocompetent Patient: A Case Report and Mini-Review.

Hatzimichael E, Papathanasiou K, Zerdes I, Flindris S, Papoudou-Bai A, Kapsali E.

Case Rep Hematol. 2017;2017:2861596. doi: 10.1155/2017/2861596. Epub 2017 Nov 20.

3.

Orbital plasmablastic lymphoma.

Bloch E, Robinson F.

Clin Case Rep. 2017 Nov 24;6(1):222-223. doi: 10.1002/ccr3.1281. eCollection 2018 Jan.

4.

MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma.

Ambrosio MR, Mundo L, Gazaneo S, Picciolini M, Vara PS, Sayed S, Ginori A, Lo Bello G, Del Porro L, Navari M, Ascani S, Yonis A, Leoncini L, Piccaluga PP, Lazzi S.

Oncotarget. 2017 Oct 31;8(64):107356-107373. doi: 10.18632/oncotarget.22219. eCollection 2017 Dec 8.

5.

Oral plasmablastic lymphoma as the first manifestation of AIDS.

Vale DAD, Rogado CM, Carvalho DLC, Trierveiler M, Ortega KL.

An Bras Dermatol. 2017;92(5 Suppl 1):110-112. doi: 10.1590/abd1806-4841.20175417.

6.

Unusual presentation of plasmablastic lymphoma involving ovarian mature cystic teratoma: a case report.

Hadžisejdić I, Babarović E, Vranić L, Duletić Načinović A, Lučin K, Krašević M, Jonjić N.

Diagn Pathol. 2017 Nov 29;12(1):83. doi: 10.1186/s13000-017-0672-x.

7.

Plasmablastic Lymphoma: Case Report of Prolonged Survival of an Advanced Human Immunodeficiency Patient and Literature Review.

Rafei H, El-Bahesh E, Finianos A, Liu ML, Schechter GP.

Case Rep Hematol. 2017;2017:9561013. doi: 10.1155/2017/9561013. Epub 2017 Sep 24.

8.

Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?

Beltran BE, Quiñones P, Sanchez G, Paredes A, Moises C, Cotrina E, Torres-Cabala CA, Miranda RN, Castillo JJ.

Leuk Lymphoma. 2018 Jul;59(7):1753-1755. doi: 10.1080/10428194.2017.1393666. Epub 2017 Oct 30. No abstract available.

PMID:
29081245
9.

Durable complete remission with combination chemotherapy and bortezomib in HIV-associated plasmablastic lymphoma.

Arora N, Gupta A, Sadeghi N.

BMJ Case Rep. 2017 Oct 9;2017. pii: bcr-2017-222063. doi: 10.1136/bcr-2017-222063.

PMID:
28993364
10.

Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease.

Guerrero-Garcia TA, Mogollon RJ, Castillo JJ.

Leuk Res. 2017 Nov;62:12-16. doi: 10.1016/j.leukres.2017.09.020. Epub 2017 Sep 27. Review.

PMID:
28963907
11.

Intraocular Plasmablastic Lymphoma in a HIV Patient.

Mariano CFA, Trevisan GL, Cruz AAVE, Chahud F.

Case Rep Pathol. 2017;2017:7693149. doi: 10.1155/2017/7693149. Epub 2017 Aug 8.

12.

Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets.

Mine S, Hishima T, Suganuma A, Fukumoto H, Sato Y, Kataoka M, Sekizuka T, Kuroda M, Suzuki T, Hasegawa H, Fukayama M, Katano H.

Sci Rep. 2017 Aug 31;7(1):10188. doi: 10.1038/s41598-017-10684-5.

13.

Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.

Phipps C, Yeoh KW, Lee YS, Nagarajan C, Gopalakrishnan S, Ho LP, Hwang WYK, Goh YT, Grigoropoulos NF.

Ann Hematol. 2017 Nov;96(11):1959-1960. doi: 10.1007/s00277-017-3109-4. Epub 2017 Aug 22. No abstract available.

PMID:
28831541
14.

11C-Methionine-Avid Plasmablastic Lymphoma.

Annunziata S, Cuccaro A, Caldarella C, Leccisotti L, Hohaus S.

Clin Nucl Med. 2017 Nov;42(11):872-873. doi: 10.1097/RLU.0000000000001803.

PMID:
28825948
15.

Plasmablastic Lymphoma in a Patient With Crohn's Disease After Extensive Immunosuppressive Therapy.

Ghosh G, Jacob V, Wan D.

Clin Gastroenterol Hepatol. 2018 Apr;16(4):e41-e42. doi: 10.1016/j.cgh.2017.07.036. Epub 2017 Aug 4. No abstract available.

PMID:
28782668
16.

Plasmablastic Lymphoma.

Bhusal S, Acharya B, Chapagain S.

JNMA J Nepal Med Assoc. 2017 Apr-Jun;56(206):271-273.

PMID:
28746329
17.

Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India.

Rudresha AH, Lakshmaiah KC, Agarwal A, Babu KG, Loknatha D, Jacob LA, Babu S, Lokesh KN, Rajeev LK.

South Asian J Cancer. 2017 Apr-Jun;6(2):69-71. doi: 10.4103/sajc.sajc_186_16.

18.

Plasmablastic lymphoma presenting as exophytic skin lesions.

El Fakih R, Almahayni M, Alsermani M.

Hematol Oncol Stem Cell Ther. 2017 Sep;10(3):164-165. doi: 10.1016/j.hemonc.2017.05.032. Epub 2017 Jul 5. No abstract available.

19.

Plasmablastic lymphoma with unfavorable chromosomal abnormalities related to plasma cell myeloma: A borderline case between plasmablastic lymphoma and plasmablastic plasma cell myeloma

Aoyama Y, Tsunemine H, Kodaka T, Oda N, Matsuoka H, Itoh T, Takahashi T.

J Clin Exp Hematop. 2017;57(1):37-39. doi: 10.3960/jslrt.16020. No abstract available.

20.

Pediatric plasmablastic lymphoma: Diagnostic and therapeutic dilemma.

Misra A, Bakhshi S, Kumar R, Chopra A.

Indian J Pathol Microbiol. 2017 Apr-Jun;60(2):303-304. doi: 10.4103/IJPM.IJPM_375_16. No abstract available.

Supplemental Content

Loading ...
Support Center